4 The December 31, 2022 balances were derived from the Company’s audited annual financial statements
Unaudited Consolidated Statements of Profit or Loss and Other Comprehensive Income | ||||||||||
Nine Months
Ended September 30, |
Three Months Ended
September 30, |
Year ended
December 31, | ||||||||
2022 | 2023 | 2022 | 2023 | 2022 | ||||||
Thousands | Thousands | Thousands | Thousands | Thousands | ||||||
USD | USD | USD | USD | USD | ||||||
Revenues | 31,529 | 41,860 | 9,998 | 12,158 | 43,633 | |||||
Cost of revenues | 21,159 | 23,186 | 7,428 | 6,739 | 24,943 | |||||
Cost of revenues - write-down of inventories and impairment of assets recognized in business combination and technology | 3,990 | 244 | 771 | 50 | 4,639 | |||||
Total cost of revenues | 25,149 | 23,430 | 8,199 | 6,789 | 29,582 | |||||
Gross profit | 6,380 | 18,430 | 1,799 | 5,369 | 14,051 | |||||
Research and development expenses | 54,770 | 48,424 | 18,535 | 12,788 | 75,763 | |||||
Sales and marketing expenses | 29,075 | 23,418 | 9,652 | 7,715 | 38,833 | |||||
General and administrative expenses | 21,366 | 44,203 | 7,417 | 20,848 | 30,457 | |||||
Impairment losses on intangible assets | — | — | — | — | 40,523 | |||||
Operating loss | (98,831 | ) | (97,615 | ) | (33,805 | ) | (35,982 | ) | (171,525 | ) |
Finance income | 13,826 | 34,592 | 7,001 | 11,101 | 22,965 | |||||
Finance expense | 18,064
| 8,385 | 1,601 | 2,031 | 11,680 | |||||
Finance income (expense) from investment in securities | (38,068 | ) | 16,967 | (38,681 | ) | (40,234 | ) | (67,791 | ) | |
Loss before taxes on income | (141,137 | ) | (54,441 | ) | (67,086 | ) | (67,146 | ) | (228,031 | ) |
Taxes benefit (expenses) | 742 | 121 | (47 | ) | 273 | (264 | ) | |||
Loss for the period | (140,395 | ) | (54,320 | ) | (67,133 | ) | (66,873 | ) | (228,295 | ) |
Loss attributable to non-controlling interests | (639 | ) | (819 | ) | (202 | ) | (269 | ) | (872 | ) |
Loss attributable to owners | (139,756 | ) | (53,501 | ) | (66,931 | ) | (66,604 | ) | (227,423 | ) |
Loss per share | ||||||||||
Basic loss per share | (0.54 | ) | (0.21 | ) | (0.26 | ) | (0.26 | ) | (0.88 | ) |
Other comprehensive income items that after initial recognition in comprehensive income were or will be transferred to profit or loss | ||||||||||
Foreign currency translation differences for foreign operations | (2,351 | ) | 344 | (1,113 | ) | (253 | ) | (844 | ) | |
Other comprehensive income items that will not be transferred to profit or loss | ||||||||||
Remeasurement of net defined benefit liability (IAS 19), net of tax | 3,127 | (1,060 | ) | — | — | 2,508 | ||||
Total other comprehensive income (loss) for the period | 776 | (716 | ) | (1,113 | ) | (253 | ) | 1,664 | ||
Total comprehensive loss for the period | (139,619 | ) | (55,036 | ) | (68,246 | ) | (67,126 | ) | (226,631 | ) |
Comprehensive loss attributable to non-controlling interests | (735 | ) | (830 | ) | (247 | ) | (284 | ) | (892 | ) |
Comprehensive loss attributable to owners of the Company | (138,884 | ) | (54,206 | ) | (67,999 | ) | (66,842 | ) | (225,739 | ) |